top of page
Aerogen Vibrating Mesh Nebuliser USB Controller With Solo And Ultra

Aerogen Vibrating Mesh Nebuliser USB Controller With Solo And Ultra

R8,694.00Price
Aerogen is a silent, high performance vibrating mesh drug delivery device that can cross multiple modalities for ventilated and non-ventilated patients. By delivering more aerosol than any other device, Aerogen can improve patient outcomes at any phase of the patient’s care.

  • AEROGEN SOLO

    Aerogen Solo – the world leader in acute care aerosol drug delivery
    Discover how the Aerogen Solo can support aerosol drug respiratory therapy at every stage of a patient's respiratory journey: during invasive mechanical ventilation (IMV) and non-
    invasive supports such as non-invasive ventilation (NIV), high-flow (HF) therapies and when self-ventilating (SV).

     

  • Aerogen Solo Key Featurs:

    • Refill medication without breaking the circuit
    • Can be used with all medications for inhalation
    • No heating or degradation of medication
    • Minimal residual volume (<0.1ml for 3ml dose)
    • High speed of delivery
    • Does not affect ventilator parameters
    • Suitable for solutions, suspensions, proteins & peptides
    • Can be placed at the wye
    • No noise

  • AEROGEN ULTRA

    Aerogen Ultra – a global leader in aerosol drug delivery


    Discover how the Aerogen Ultra – a handheld device – can be used in conjunction with the Aerogen Solo to deliver inhalation treatment either post-ventilation as part of the weaning process or during exacerbations.


    Global market presence in 75+ countries worldwide

  • Aerogen Ultra Key Features:

    • Oxygen port enables optional delivery of oxygen.


    • An ergonomic valved mouthpiece controls the flow of air through the chamber to facilitate aerosol drug delivery.


    • Aerogen Ultra, optional delivery of oxygen


    •Innovative chamber design provides an aerosol reservoir intended for optimal drug delivery

  • Effectiveness

    Aerogen Ultra facilitates effective medication delivery during self-ventilation.


    In studies, bronchodilator administration via the Aerogen Ultra was associated with:
    • 6x more medication delivered to the lungs during self-ventilation versus a jet nebuliser3
    • Significantly less medication left in the cup versus other nebulisers.

  • Patient Care

    Aerogen Ultra improves patient care in response to aerosolised medication.


    In studies, when compared with jet nebulisers, bronchodilator administration via Aerogen Ultra was associated with:

    • Significantly fewer treatments and significantly less time required to achieve symptom control


    Across all patients in an emergency department:
    • 30% relative reduction in hospital admission rates6
    • 85% of patients achieving symptom control with one 2.5 mg salbutamol dose6
    •37-minute reduction in ED median length of stay.

  • Workflow

    Aerogen simplifies the workflow.


    • Aerogen is intended for the aerosolisation of any physician-prescribed solutions for inhalation.

    • One system used throughout a patient's respiratory journey (IMV, NIV, HF, self-ventilating),2 supporting continuity of care.

    • Virtually silent delivery, keeping a calm environment for your patients.

  • NAPPY CODE:

    231595001

bottom of page